-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Oramed Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- Oramed Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.14M, a 17.3% increase year-over-year.
- Oramed Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$12.9M, a 56.4% increase year-over-year.
- Oramed Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$15.8M, a 61.2% increase from 2022.
- Oramed Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$40.6M, a 67.6% decline from 2021.
- Oramed Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$24.2M, a 106% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)